NEW MJ NEWS

AbbVie to Present at the 39th Annual J.P. Morgan Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021. Members of AbbVie’s executive leadership team will present virtually at 3:30 p.m. Central time, including Richard A. Gonzalez, chairman of the board and chief executive officer, Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision
Cision
View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-39th-annual-jp-morgan-healthcare-conference-301201327.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

The Alkaline Water Company Inc. (WTER) (WTER.V) Company Expands Portfolio with the Launch of the Company’s First Canned Product Lines

The Alkaline Water Company Expands Portfolio with the Launch of the Company’s…

$FWDG Subsidiary Receives Product of the Year Award

FutureWorld (FWDG) Subsidiary CB Scientific Awarded Product of the Year from the…

22nd Century Group, Inc. (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and Distribution Agreement with Cookies

22nd Century Group (XXII) Announces Fully Integrated, Single-Source Strategic License, Manufacturing and…

$TAUG Appoints 20 Year Pharmaceutical Industry Veteran to its Board of Advisors

Tauriga Sciences Inc. Appoints 20 Year Pharmaceutical Industry Veteran to its Board…